ExoCoBio

Our Exosomes Your Future

Seoul, South Korea · $9.3M raised

Headquarters
Seoul
Employees
51–200
Business Model
B2B2C
Total Funding
$9.3M
Last Round
$9.3M Series CAug 2020
Rounds
1

About

ExoCoBio is a Seoul-based biotechnology company and global leader in the development of exosome-based cosmeceutical and biopharmaceutical products. The company's proprietary ExoSCRT™ technology enables the production of high-purity, high-efficacy exosomes used across regenerative aesthetics, therapeutic, and immuno-oncology applications. ExoCoBio's product portfolio spans professional skin and hair care lines (ASCE+), consumer cosmetics, and bio-ingredient raw materials (ExoBRID, Vexosome, Rose Exosome) licensed to cosmetics manufacturers worldwide. On the pharmaceutical side, the company advances regenerative therapeutics and immuno-oncology pipelines leveraging exosome biology. In 2023, ExoCoBio entered a business combination with BENEV, achieving combined revenues of approximately KRW 68 billion.

Summary

ExoCoBio is a Biotech company based in Seoul, South Korea. It has raised $9.3M in total across 1 round, most recently a $9.3M Series C round in Aug 2020. Investors include K2 Investment Partners, SBI Investment Korea and DT & Investment.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CAug 2020
$9.3M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ExoCoBio on Indexed.vc
<a href="https://indexed.vc/companies/exocobio"><img src="https://indexed.vc/api/badge/company/exocobio" alt="ExoCoBio on Indexed.vc" width="260" height="76" /></a>